Back HIV Treatment Treatment Guidelines

HIV Treatment Guidelines

IAS 2015: START Trial Provides Definitive Evidence of Benefits of Early HIV Treatment

People who start antiretroviral therapy (ART) immediately after an HIV diagnosis -- while their CD4 T-cell count is still high -- rather than waiting until it falls below 350 cells/mm3 have a significantly lower risk of illness and death, according to long-awaited findings from the START trial presented at the 8th International AIDS Society Conference this week in Vancouver and published simultaneously in the July 20 advance edition of the New England Journal of Medicine.

alt

Read more:

IAS 2015: World Health Organization to Recommend HIV Treatment for All

The World Health Organization (WHO) will issue new HIV treatment guidelines later this year recommending treatment for all, regardless of CD4 cell count, Dr. Meg Doherty of the WHO Department of HIV/AIDS told a satellite meeting ahead of the 8th International AIDS Society Conference (IAS 2015) in Vancouver on Sunday.

alt

Read more:

DHHS Updates Antiretroviral Treatment Guidelines for Adults and Children

The U.S. Department of Health and Human Services (DHHS) has released updated versions of its antiretroviral treatment guidelines for adults and adolescents, and for children with HIV. The new adult guidelines include revised recommendations for first-line antiretroviral therapy (ART) as well as management of treatment-experienced patients. The revised pediatric guidelines include a discussion of very early treatment for HIV-infected infants.

alt

Read more:

New British Guidelines Recommend Treatment for Everyone with HIV

Everyone with HIV who is prepared to take antiretroviral treatment should receive it, regardless of CD4 cell count, new draft British HIV Association (BHIVA) treatment guidelines recommend. The new draft guidelines, published for consultation this week, say that anyone living with HIV who understands the commitment of antiretroviral therapy and is ready to start should receive treatment. The change -- from a recommendation to start treatment before the CD4 cell count falls below 350 cells/mm3 to treatment for all -- follows the results of the START trial, a keenly awaited international study of when to start treatment.

alt

Read more:

Updated Antiretroviral Treatment Guidelines Include Cost Considerations

The U.S. Department of Health and Human Services (DHHS) this week released an update to its Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Among the major changes are the addition of a new section on cost considerations and a recommendation for less frequent CD4 T-cell monitoring for people without advanced disease.

alt

Read more: